Retail sale of pharmaceutical products
APOMED AS
Revenue 2024
NOK 15.2m
Operating profit
NOK −20.3m
Equity
NOK −15.2m
Incorporated
2020
Employees
10
Share capital
NOK 1.0m
Key figures · 2024
Current ratio
0.34
Equity ratio
-328.7%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -133.8% | |
| Net margin (%%) | -137.3% | |
| Return on assets (%%) | -439.2% | |
| Likviditet | ||
| Current ratio | 0.34 | |
| Working capital | −3.8m | |
| Soliditet | ||
| Equity ratio (%%) | -328.7% | |
| Debt-to-equity ratio | -1.30 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.